Sometimes more lessons are learned from failures than successes. I've learned quite a bit from working through the challenges of this trial. #NephJC
06.08.2025 01:56 โ ๐ 11 ๐ 3 ๐ฌ 1 ๐ 2@jeyakumarmeyyappan.bsky.social
Nephrologist , transplant physician
Sometimes more lessons are learned from failures than successes. I've learned quite a bit from working through the challenges of this trial. #NephJC
06.08.2025 01:56 โ ๐ 11 ๐ 3 ๐ฌ 1 ๐ 2๐Check out the VA for HiLO by @sejalplakhani.bsky.social
๐ This should be quite the discussion, don't miss it!
#NephJC #NephSky
www.nephjc.com/news/2025/8/4/the-hilo-trial-visual-abstract
HiLo, HiLo it's off to work we go! โ๏ธ
Join us 9 pm EST 8/5/25 to discuss. #NephJC #NephSky
Controlling Phos in patients on HD is a lot of work, but is it worth it? HiLo looks at hospitalization & death in low/high Phos goals. Will we finally have a RCT with answers โ๏ธ
www.nephjc.com/news/hilo-tr...
Severe AKI in the ICU: Management ca. 2025
#Nephpearls #AKIinICU #NephSky
๐๐ผ pubmed.ncbi.nlm.nih.gov/40578821/
#nephjc
Hello all ,
Jeyakumar from India .
I stick to creatinine for most decisions.
Would love to know about the gap though
Great job Marc @msocomd.bsky.social . :) #NephJC
09.07.2025 01:59 โ ๐ 3 ๐ 0 ๐ฌ 0 ๐ 0Agree. The trial meant to see if starting agents upfront can make adifference. The point is these patients anyway wud have started the other pillars in sequence if made available. UACR (already < 1 gram ) & its reduction by 52% not strong point to start 2gether. Can still go in sequence #NephJC
09.07.2025 01:56 โ ๐ 2 ๐ 0 ๐ฌ 1 ๐ 0The next trial should measure hard outcomes like mortality and ESKD.
Albuminuria reduction and the eGFR are dip were expected and go hand in hand. #NephJC.
Also the reason why they must have had screening failure of more than 50 percent .
In reality , I donโt mind if my patient s eGFR was more than 45 and his potassium is 5.5.
Would just Flozinate and be happy.
#NephJC
My approach with the #nsmra when egfr less than 45-50 ie #flozin first. If egfr over 45 start both at the same time because #YOLO
#Nephjc
98% on ACEi /ARB and still have potassium less than 4.8 . Not what we see always #NephJC
09.07.2025 01:28 โ ๐ 2 ๐ 1 ๐ฌ 2 ๐ 0SGLT2 also phylogenetically an older system than RASi #NephJC
09.07.2025 01:25 โ ๐ 3 ๐ 1 ๐ฌ 1 ๐ 0#NephJC
09.07.2025 01:18 โ ๐ 0 ๐ 0 ๐ฌ 0 ๐ 0I think 30 mg /day will be where we are headed. ( The Push just like how lipid targets in CVD kept getting lower) #NephJC. But 500 mg/day for now
09.07.2025 01:15 โ ๐ 3 ๐ 1 ๐ฌ 0 ๐ 0Thank you Swap. With plenty of help from the NephJC faculty . Thanks to you and all of them . I am more CONFIDENT #NephJC
09.07.2025 01:06 โ ๐ 4 ๐ 0 ๐ฌ 1 ๐ 0#NephJC
Hello all.
This is Jeyakumar from Lucknow.
No COI
With unshakable CONFIDENCE, finerenone and empagliflozin waltz into diabetic kidney disease - turning 'maybe someday' into 'why not today?'
#NephJC summary by @sejalplakhani.bsky.social and @jeyakumarmeyyappan.bsky.social
#MedSky
www.nephjc.com/news/confide...
Check out the blog summary . CONFIDENCE
How confident are we starting sglt 2 i + nsmra upfront for patients with diabetes and kidney diseases ?
www.nephjc.com/news/confide...
Check out the latest KDIGO Direct: kdigo.co/KDIGO-Direct...
In this issue:
๐ Nephrotic Syndrome in Children GL publishes
๐ข Dr. Wanner elected KDIGO Co-Chair
๐ KDIGO mourns Dr. Rinaldo Bellomo
๐ KDIGO convenes Green Dialysis Conference
๐๏ธ KDIGO at #ERA25
๐ฅ New resources on #ADPKD, #C3G, #CKM & #IgAN
๐Want to get my attention...start bleeding ๐ฉธ
Hey #NephSky #NephJC fans!
Check out the VA on ddAVP and kidney biopsy bleeding for tonite's discussion on #bluesky at 9pm by Dr. Divya Bajpai
www.nephjc.com/news/2025/5/13/desmopressin-for-kidney-biopsy-the-visual-abstract